Sevoflurane Impairs Insulin Secretion and Tissue-Specific Glucose Uptake In Vivo
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Sevoflurane Impairs Insulin Secretion and Tissue-Specific Glucose Uptake In Vivo. / Høyer, Kasper F.; Nielsen, Thomas S.; Risis, Steve; Treebak, Jonas T.; Jessen, Niels.
In: Basic & Clinical Pharmacology & Toxicology, Vol. 123, No. 6, 2018, p. 732-738.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Sevoflurane Impairs Insulin Secretion and Tissue-Specific Glucose Uptake In Vivo
AU - Høyer, Kasper F.
AU - Nielsen, Thomas S.
AU - Risis, Steve
AU - Treebak, Jonas T.
AU - Jessen, Niels
N1 - This article is protected by copyright. All rights reserved.
PY - 2018
Y1 - 2018
N2 - The use of anaesthetics severely influences substrate metabolism. This poses challenges for patients in clinical settings and for the use of animals in diabetes research. Sevoflurane can affect regulation of glucose homeostasis at several steps, but the tissue-specific response remains to be determined. The aim of the study was to investigate the pharmacological effect of sevoflurane anaesthesia on glucose homeostasis during hyperinsulinaemic clamp conditions, the gold standard method for assessment of whole-body insulin sensitivity. Conscious mice (n=6) and mice under sevoflurane anaesthesia (n=8) underwent a hyperinsulinaemic clamp where constant infusion of insulin and donor blood was administered during variable glucose infusion to maintain isoglycaemia. 2-[1-14 C]-deoxy-D-glucose was infused to determine tissue-specific uptake of glucose in adipose tissue, heart, brain and skeletal muscle. Sevoflurane anaesthesia severely impaired insulin-stimulated whole-body glucose uptake demonstrated by a 50% lower glucose infusion rate (GIR). This was associated with decreased glucose uptake in brain, soleus, triceps and gastrocnemius muscles in sevoflurane-anaesthetized mice compared to conscious mice. Plasma Free Fatty Acids (FFA), a potent inducer of insulin resistance, increased by 42% in mice during sevoflurane anaesthesia. In addition, insulin secretion from pancreatic β-cell was lower in fasted, anaesthetized mice. Sevoflurane anaesthesia impairs insulin secretion, induces insulin resistance in mice and reduces glucose uptake in non-insulin sensitive tissue like the brain. The underlying mechanisms may involve sevoflurane-induced mobilization of FFA. This article is protected by copyright. All rights reserved.
AB - The use of anaesthetics severely influences substrate metabolism. This poses challenges for patients in clinical settings and for the use of animals in diabetes research. Sevoflurane can affect regulation of glucose homeostasis at several steps, but the tissue-specific response remains to be determined. The aim of the study was to investigate the pharmacological effect of sevoflurane anaesthesia on glucose homeostasis during hyperinsulinaemic clamp conditions, the gold standard method for assessment of whole-body insulin sensitivity. Conscious mice (n=6) and mice under sevoflurane anaesthesia (n=8) underwent a hyperinsulinaemic clamp where constant infusion of insulin and donor blood was administered during variable glucose infusion to maintain isoglycaemia. 2-[1-14 C]-deoxy-D-glucose was infused to determine tissue-specific uptake of glucose in adipose tissue, heart, brain and skeletal muscle. Sevoflurane anaesthesia severely impaired insulin-stimulated whole-body glucose uptake demonstrated by a 50% lower glucose infusion rate (GIR). This was associated with decreased glucose uptake in brain, soleus, triceps and gastrocnemius muscles in sevoflurane-anaesthetized mice compared to conscious mice. Plasma Free Fatty Acids (FFA), a potent inducer of insulin resistance, increased by 42% in mice during sevoflurane anaesthesia. In addition, insulin secretion from pancreatic β-cell was lower in fasted, anaesthetized mice. Sevoflurane anaesthesia impairs insulin secretion, induces insulin resistance in mice and reduces glucose uptake in non-insulin sensitive tissue like the brain. The underlying mechanisms may involve sevoflurane-induced mobilization of FFA. This article is protected by copyright. All rights reserved.
U2 - 10.1111/bcpt.13087
DO - 10.1111/bcpt.13087
M3 - Journal article
C2 - 29956485
VL - 123
SP - 732
EP - 738
JO - Basic and Clinical Pharmacology and Toxicology
JF - Basic and Clinical Pharmacology and Toxicology
SN - 1742-7835
IS - 6
ER -
ID: 200460848